SLC39A1 Contributes to Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma by Activating AMPK Signaling. Bangladesh J Pharmacol 2024, 19 (2), 52-58. https://doi.org/10.3329/bjp.v19i2.72787.